AbCellera Biologics Inc.
ABCL
Classement en actions
#4047
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Prix de l'action
$12.29
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$3.98B
Changement (1 jour)
4.95%
Changement (1 an)
124.68%
Pays
CA
Échange AbCellera Biologics Inc. (ABCL)
Catégorie
Healthcare
Historique du prix de l'action pour AbCellera Biologics Inc. (ABCL)
Prix de clôture le plus élevé : $12.67 le 2026-10-01
Prix de clôture le plus bas : $45.73 le 2020-12-01
Prix de clôture le plus bas : $45.73 le 2020-12-01
Historique du prix de l'action de AbCellera Biologics Inc. de 2020 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 69.44% |
| 2025 | 23.13% |
| 2024 | -44.83% |
| 2023 | -50.84% |
| 2022 | -25.40% |
| 2021 | -68.67% |
| 2020 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
